CD38 and B-cell chronic lymphocytic leukemia: There were also no differences in the expression of MYD88 in CD38+ CLL patients compared to CD38− in PBMC with a median 0.2112 vs. 0.1778 (p = 0.867), respectively, as well as in BMMC with a median 0.1553 vs.0.1636 (p = 0.1855), respectively.